Taratingan, John .
HRN: 24-45-15 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
02/08/2025
02/14/2025
PO
3ml
Q12h
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes